Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) is pleased to see heightened investor interest following a recent interview with the CEO of Safety Strips, a Safe Supply portfolio company.

The interview with Safety Strips CEO Geoff Benic highlighted the company's active role in combating the opioid crisis through innovative drug detection technologies. With global attention on the escalating dangers of fentanyl and xylazine, investors are increasingly focusing on companies developing solutions to combat these dangerous substances.

According to a recent industry snapshot by InvestorIdeas.com, the opioid overdose treatment market is expected to reach $1.54 billion in 2024, driven by the rise in fentanyl-related overdoses. Greenlane Holdings, Inc. (NASDAQ: GNLN), a trusted name in cannabis accessories and drug testing products, recently partnered with Safety Strips to distribute fentanyl, xylazine, and drink-spike detection test strips across North America.

Innovative Solutions to Combat Fentanyl and Xylazine

Through Safety Strips Inc., Safe Supply Streaming is making significant strides in the fight against dangerous drugs. Safety Strips' highly reliable and affordable detection products are set to launch on September 25, 2024, with shipments beginning on October 1, 2024, through Greenlane's online platforms and wholesale portals. These test strips provide a quick, easy-to-use solution for consumers, offering a critical tool in preventing accidental overdoses and drink-spiking incidents.

By leveraging Greenlane's robust distribution network, Safety Strips will reach a broad audience, from individual consumers to bars and clubs that are now required by California law (Assembly Bill No. 1013) to offer drink-spiking detection kits.

Growing Market Demand and Value for Shareholders

As the demand for effective drug detection solutions rises, Safe Supply Streaming is positioned to capitalize on the growing market for safety products. The launch of Safety Strips' detection kits is expected to generate significant shareholder value, reinforcing the company's commitment to fighting the fentanyl epidemic. Safe Supply's products, validated to meet ISO 13485 standards, offer consumers peace of mind in a world where dangerous substances are becoming increasingly prevalent.

Safe Supply, Chief Executive Officer, Bill Panagiotakopoulos Comments: "We are actively exploring partnerships and engaging with key players within the medical technology ecosystem to expand the scope of Safety Strips. Our close collaboration with Geoff and his team has been instrumental in driving progress, and we're thrilled by the visibility our partner, Greenlane, has brought to this critical issue. While fentanyl detection is a significant focus, it's only the beginning. Our test strip portfolio is extensive, and we're particularly excited about several upcoming tests that will further address urgent public safety needs. We look forward to sharing more details with the market in the near future."